P. Upcroft

K. S. W. Tan1
P. Vanelle1
T. Terme1
1K. S. W. Tan
1P. Vanelle
Learn More
  • L. A. Dunn, K. S. W. Tan, P. Vanelle, T. Juspin, M. D. Crozet, T. Terme +2 others
  • 2012
Metronidazole (MTR) is frequently used for the treatment of Blastocystis infections, but with variable effectiveness, and often with treatment failures as a possible result of drug resistance. We have developed two Blastocystis MTR-resistant (MTRR) subtype 4 WR1 lines (WR1-M4 and WR1-M5), with variable susceptibility to a panel of anti-protozoal agents(More)
  • 1